In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel talk about how employees need to be consciously inclusive and why their actions should be measured not just by what they achieve but by how they go about it. Collecting data is beneficial, but it becomes even more meaningful when employees see how their input translates into action. Creating a strategic plan can offer clear goals to work toward.
Planning for Unique Challenges Faced by Cell & Gene Therapy Developers
May 8th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, discusses the unique challenges that developers of cell and gene therapies need to plan for when building their channel strategy.
Pricing Climate Impacting Commercial Considerations
May 3rd 2024In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, talks about the influence of Medicare Part D drug price negotiations on manufacturer go-to-market strategies and decision-making, and the industry’s response to the wider dialogue on pricing transparency.